Ryan Lydon, MD
Vascular Surgery · Rochester, NYNPI 1407297260
Payments from drug & device makers
Across 675 payments — averaging $76.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$25K
- W. L. Gore & Associates, Inc.$18K
- Silk Road Medical, Inc.$2K
- Endologix LLC$2K
- Terumo Medical Corporation$1K
- Inari Medical, Inc.$1K
- plus $3K from 16 others
What the payments were for
- Consulting fees$9,61019%
- Speaking & faculty fees$1,4633%
- Travel & lodging$11,72823%
- Food & beverage$28,60856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 466 | $24,853 |
| W. L. Gore & Associates, Inc. | 100 | $17,848 |
| Silk Road Medical, Inc. | 17 | $2,131 |
| Endologix LLC | 11 | $1,564 |
| Terumo Medical Corporation | 23 | $1,085 |
| Inari Medical, Inc. | 10 | $1,038 |
| Stryker | 3 | $434 |
| Penumbra, Inc. | 7 | $421 |
| Argon Medical Devices, Inc. | 1 | $350 |
| Abbott | 4 | $302 |
| Johnson & Johnson | 17 | $300 |
| Bolton Medical Inc | 2 | $213 |
| Philips North America LLC | 3 | $206 |
| Integra Lifesciences Corporation | 2 | $159 |
| Shape Memory Medical Inc. | 2 | $133 |
| Convatec Inc. | 1 | $102 |
| Acell, Inc. | 1 | $98 |
| Contego Medical, Inc | 1 | $70 |
| Baxter Healthcare | 1 | $36 |
| Globus Medical | 1 | $33 |
| Pfizer | 1 | $16 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE VIABAHN VBX Balloon Expandable Endo$8,592
- GORE EXCLUDER AAA Endoprosthesis$7,789
- Abre$7,207
- GORE EXCLUDER Iliac Branch Endoprosthesis$4,699
- GORE TAG Thoracic Endoprosthesis$4,480
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$3,960
- GORE VIABAHN Endoprosthesis$3,060
- ENROUTE Transcarotid Neuroprotection System$2,128
- ENROUTE Transcarotid Stent$1,955
- HawkOne$1,636
- FLOWTRIEVER CATHETER, S$1,283
- Product in Development$1,260
- Alto Abdominal Stent Graft System$1,219
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,190
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,029
- CT THROMBECTOMY SYSTEM KIT$708
- GORE TAG Conformable Thoracic Endoprosthesis$657
- IN.PACT Admiral$650
- GORE VIABAHN Endoprosthesis with Heparin$481
- R2P MISAGO$350
How this compares
$51,408 in reported general payments places this provider in the 85th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $14,799 |
| Gabapentin | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $14,79925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 405 vascular surgery providers in New York.
Other vascular surgery in Rochester
- Michael StonerRochester$328K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.7M
- John LantisNew York$1.4M
- Sonya NoorBuffalo$1.2M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
- James McKinseyNew York$750K
- Peter FariesNew York$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.